ABVX
Abivax·NASDAQ
--
--(--)
--
--(--)
ABVX fundamentals
Abivax (ABVX) released its earnings on Mar 23, 2026: revenue was 2.21M (YoY --), beat estimates; EPS was -1.1725 (YoY --), beat estimates.
Revenue / YoY
2.21M
--
EPS / YoY
-1.1725
--
Report date
Mar 23, 2026
EPS
Actual | -0.9695 | -0.97 | -2.4717 | -1.1725 | |||
Forecast | -0.7556 | -0.9287 | -0.7865 | -1.3534 | |||
Surprise | 0.00% | 0.00% | 0.00% | -28.31% | -4.45% | -214.27% | +13.37% |
Revenue
Actual | -- | -- | -- | 1.16M | 1.33M | 2.40M | 2.21M |
Forecast | -- | -- | -- | 3.35M | 1.39M | 1.35M | 1.80M |
Surprise | 0.00% | 0.00% | 0.00% | -65.30% | -4.61% | +78.51% | +22.41% |
Earnings Call
You can ask Aime
What factors drove the changes in Abivax's revenue and profit?What is the revenue and EPS growth rate for Abivax year over year?What does Abivax do and what are its main business segments?What were the key takeaways from Abivax's earnings call?What were the key takeaways from Abivax’s earnings call?What guidance did Abivax's management provide for the next earnings period?Did Abivax beat or miss consensus estimates last quarter?What is Abivax's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
